BMS-195614, CAS [[182135-66-6]]

Produktübersicht

• Artikelname: BMS-195614, CAS [[182135-66-6]]
• Artikelnummer: MCE-HY-101259
• Hersteller Artikelnummer: HY-101259
• Alternativnummer: MCE-HY-101259-25MG,MCE-HY-101259-50MG,MCE-HY-101259-5MG,MCE-HY-101259-1MG,MCE-HY-101259-100MG,MCE-HY-101259-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: BMS 614

Produktbeschreibung

BMS-195614 (BMS 614) is an orally active neutral RARalpha-selective antagonist with a Ki of 2.5 nM. BMS-195614 restores the expression of Bcl2. BMS-195614 inhibits the transactivation of NF-kappaB, AP-1 and PPAR. BMS-195614 downregulates the expression of IL-6 and VEGF. BMS-195614 reduces blue light-induced phototoxicity and inhibits cell migration. BMS-195614 modulates inflammation and angiogenesis[1][2][3][4][5].

Produkteigenschaften

• Molekulargewicht: 448.51
• Reinheit: 99.5
• CAS Nummer: [182135-66-6]
• Formel: C29H24N2O3
• Target-Kategorie: Bcl-2 Family,Interleukin Related,NF-kappaB,PPAR,RAR/RXR,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound